DK1144386T3 - Polymorphic form of telmisartan, process for its preparation and use thereof for the manufacture of a drug - Google Patents

Polymorphic form of telmisartan, process for its preparation and use thereof for the manufacture of a drug

Info

Publication number
DK1144386T3
DK1144386T3 DK00901510T DK00901510T DK1144386T3 DK 1144386 T3 DK1144386 T3 DK 1144386T3 DK 00901510 T DK00901510 T DK 00901510T DK 00901510 T DK00901510 T DK 00901510T DK 1144386 T3 DK1144386 T3 DK 1144386T3
Authority
DK
Denmark
Prior art keywords
telmisartan
drug
manufacture
preparation
polymorphic form
Prior art date
Application number
DK00901510T
Other languages
Danish (da)
Inventor
Heinrich Schneider
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1144386T3 publication Critical patent/DK1144386T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK00901510T 1999-01-19 2000-01-07 Polymorphic form of telmisartan, process for its preparation and use thereof for the manufacture of a drug DK1144386T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19901921A DE19901921C2 (en) 1999-01-19 1999-01-19 Polymorphs of telmisartan, process for their preparation and their use in the manufacture of a medicament
PCT/EP2000/000065 WO2000043370A1 (en) 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament

Publications (1)

Publication Number Publication Date
DK1144386T3 true DK1144386T3 (en) 2004-01-12

Family

ID=7894715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00901510T DK1144386T3 (en) 1999-01-19 2000-01-07 Polymorphic form of telmisartan, process for its preparation and use thereof for the manufacture of a drug

Country Status (36)

Country Link
EP (1) EP1144386B1 (en)
JP (1) JP4700813B2 (en)
KR (1) KR100658959B1 (en)
CN (1) CN1144790C (en)
AR (1) AR035475A1 (en)
AT (1) ATE252564T1 (en)
AU (1) AU765081B2 (en)
BG (1) BG65027B1 (en)
BR (1) BR0007584A (en)
CA (1) CA2352436C (en)
CO (1) CO5150238A1 (en)
CZ (1) CZ297412B6 (en)
DE (2) DE19901921C2 (en)
DK (1) DK1144386T3 (en)
EA (1) EA003065B1 (en)
EE (1) EE04344B1 (en)
ES (1) ES2208265T3 (en)
HK (1) HK1041485B (en)
HR (1) HRP20010514B1 (en)
HU (1) HU227401B1 (en)
IL (2) IL143634A0 (en)
MY (1) MY122755A (en)
NO (1) NO319823B1 (en)
NZ (1) NZ513528A (en)
PE (1) PE20001362A1 (en)
PL (1) PL211829B1 (en)
PT (1) PT1144386E (en)
RS (1) RS50044B (en)
SA (1) SA99200838B1 (en)
SK (1) SK285429B6 (en)
TR (1) TR200102074T2 (en)
TW (1) TWI280241B (en)
UA (1) UA56358C2 (en)
UY (1) UY25980A1 (en)
WO (1) WO2000043370A1 (en)
ZA (1) ZA200104771B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153737A1 (en) * 2001-10-31 2003-05-28 Boehringer Ingelheim Pharma Crystalline sodium salt of telmisartan, process for its preparation and its use for the manufacture of a medicament
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
EP1854454B1 (en) 2002-01-16 2013-11-06 Boehringer Ingelheim Pharma GmbH & Co. KG Method for the preparation of amorphous telmisartan
DE10314702A1 (en) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
KR20080112424A (en) 2004-10-15 2008-12-24 테바 파마슈티컬 인더스트리즈 리미티드 Process for preparing telmisartan
WO2006044754A2 (en) 2004-10-18 2006-04-27 Dr. Reddy's Laboratories Ltd. Process for preparing telmisartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
WO2010133638A1 (en) 2009-05-20 2010-11-25 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical oral telmisartan solution
PL2443094T3 (en) 2009-06-19 2013-08-30 Krka Tovarna Zdravil D D Novo Mesto Process for the preparation of telmisartan
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
WO2011002425A2 (en) 2009-07-02 2011-01-06 Bilgig Mahmut Pharmaceutical composition increasing solubility and stability
EP2448576A2 (en) 2009-07-02 2012-05-09 Mahmut Bilgic Solubility enhancing pharmaceutical composition
WO2012055941A1 (en) 2010-10-27 2012-05-03 Krka,Tovarna Zdravil, D. D., Novo Mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
ITMI20102416A1 (en) * 2010-12-27 2012-06-28 Chemelectiva S R L INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE AND PROCESS FOR ITS PREPARATION
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
JP6147546B2 (en) * 2013-04-10 2017-06-14 株式会社トクヤマ Method for producing telmisartan A-type crystals with reduced acetic acid
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP6275596B2 (en) * 2014-09-03 2018-02-07 株式会社トクヤマ Method for producing ammonium salt of telmisartan
JP5871294B1 (en) 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Immediate release oral tablets
KR20170001921A (en) 2015-06-26 2017-01-05 대원제약주식회사 A pharmaceutical composition comprising telmisartan with increased stability and a preparation method thereof
KR20170012703A (en) 2015-07-22 2017-02-03 대원제약주식회사 A pharmaceutical composition comprising telmisartan and a preparation method thereof
EP3463309B1 (en) 2016-05-30 2020-06-17 Boehringer Ingelheim International GmbH Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
KR102044223B1 (en) * 2016-09-12 2019-11-13 성균관대학교산학협력단 Solid dispersions comprising Telmisartan and the preparation method thereof
CN106749037B (en) * 2016-12-21 2019-06-21 山东大学 A kind of unformed Telmisartan-glutaric acid eutectic and its preparation method and application
CN106749036B (en) * 2016-12-21 2019-06-21 山东大学 A kind of unformed Telmisartan-pimelic acid eutectic and its preparation method and application
NZ759782A (en) 2017-07-07 2023-06-30 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
CN109851562A (en) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 A kind of Telmisartan crystal and preparation method thereof
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (en) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoles, drugs with this compounds, and process for their preparation
US5139114A (en) * 1991-03-18 1992-08-18 Abex Corporation Visible brake block wear indicator

Also Published As

Publication number Publication date
NO20013560L (en) 2001-09-18
SK10202001A3 (en) 2001-12-03
KR100658959B1 (en) 2006-12-19
RS50044B (en) 2008-11-28
JP2002535315A (en) 2002-10-22
SK285429B6 (en) 2007-01-04
IL143634A0 (en) 2002-04-21
HRP20010514B1 (en) 2010-01-31
CN1144790C (en) 2004-04-07
EP1144386B1 (en) 2003-10-22
NO20013560D0 (en) 2001-07-18
EE200100375A (en) 2002-10-15
TR200102074T2 (en) 2001-12-21
ATE252564T1 (en) 2003-11-15
DE19901921C2 (en) 2001-01-04
WO2000043370A1 (en) 2000-07-27
HU227401B1 (en) 2011-05-30
NO319823B1 (en) 2005-09-19
AU765081B2 (en) 2003-09-11
HK1041485B (en) 2004-10-08
UA56358C2 (en) 2003-05-15
BG105654A (en) 2002-01-31
AR035475A1 (en) 2004-06-02
ES2208265T3 (en) 2004-06-16
PE20001362A1 (en) 2000-12-15
CO5150238A1 (en) 2002-04-29
NZ513528A (en) 2003-08-29
AU2288100A (en) 2000-08-07
PT1144386E (en) 2004-03-31
TWI280241B (en) 2007-05-01
HK1041485A1 (en) 2002-07-12
UY25980A1 (en) 2001-08-27
HRP20010514A2 (en) 2002-08-31
HUP0105148A3 (en) 2003-01-28
DE19901921A1 (en) 2000-08-03
DE50004150D1 (en) 2003-11-27
SA99200838B1 (en) 2006-03-06
EE04344B1 (en) 2004-08-16
EA003065B1 (en) 2002-12-26
EA200100730A1 (en) 2002-02-28
HUP0105148A2 (en) 2002-07-29
CA2352436C (en) 2010-03-23
IL143634A (en) 2006-10-05
MY122755A (en) 2006-05-31
YU51101A (en) 2004-05-12
BR0007584A (en) 2001-11-06
PL211829B1 (en) 2012-06-29
ZA200104771B (en) 2002-12-02
CZ20012634A3 (en) 2001-10-17
PL349425A1 (en) 2002-07-29
CA2352436A1 (en) 2000-07-27
JP4700813B2 (en) 2011-06-15
BG65027B1 (en) 2006-12-29
KR20010101552A (en) 2001-11-14
CZ297412B6 (en) 2006-12-13
EP1144386A1 (en) 2001-10-17
CN1336920A (en) 2002-02-20

Similar Documents

Publication Publication Date Title
DK1144386T3 (en) Polymorphic form of telmisartan, process for its preparation and use thereof for the manufacture of a drug
DK1180518T3 (en) 5-pyridyl-1,3-azole compounds, process for their preparation and use thereof
NO20035696D0 (en) Crystalline anti-cholinergic, process for its preparation and use thereof for the manufacture of a drug
NO20031694L (en) Crystalline monohydrate, process for its preparation and use thereof for the manufacture of a drug
DK1218341T3 (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as a drug
DK1345910T3 (en) Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
IS2223B (en) Process for the preparation of 5-cyanothalide
NO20015149D0 (en) New pharmaceutical preparation
DK1275397T3 (en) Local drug
DK1147075T3 (en) Process for Preparation of L-Phenylephrine Hydrochloride
EE200100422A (en) Epothilone derivatives, process for their preparation and pharmaceutical use
DK1202996T3 (en) Titanium compounds, manufacture and use thereof
NO20015148L (en) New pharmaceutical preparation
IS7153A (en) A process for the preparation of a 14-hydroxynormorphinone derivative
DK1627631T3 (en) Morphine sulfate microgranules, process for their preparation and preparation comprising the same
NO20010219L (en) Polycyclic thiazolidin-2-ylidenamines, process for their preparation and their use as a drug
NO20001909D0 (en) Process and plant for the preparation of 1,2-dichloroethane
NO20015104L (en) New pharmaceutical preparation
DK1053224T3 (en) Biphenylfulphonylcyanamides, process for their preparation and use thereof as a drug
NO20015105L (en) New pharmaceutical preparation
NO20042022L (en) Solid drug formulation containing pipiperazine urea derivative and process for preparing the formulation
NO20021036D0 (en) Pharmaceutical preparation
NO20020308D0 (en) Process for the preparation of epothiolone B and derivatives, as well as intermediates for the process
DK1029867T3 (en) Process for the preparation of organic azides